Federal Agency · National Institutes of Health
Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)
Posted December 30, 2024
Funding
Up to $400K
Closes
November 5, 2028
NAICS
541714
The purpose of this Notice of Funding Opportunity (NOFO) is tofurther elucidate the mechanisms of early immune development in utero, during the early post-natal period and during early childhood in neonates, infants, and children and adolescents with or without in-utero exposure to HIV or Anti-Retroviral Therapeutics (ART).This initiative aims to understand intricate mechanisms of immune cells at the maternal-fetal interface, T and B cell development and maturation in offspring, and local immune responses and the role of systemic immunity.
Eligibility
Funded by NIH and Programs related to early childhood.
Award details
Award range: Up to $400K. Applications close on November 5, 2028 (922 days remaining).
Categories
Not categorized
Sign up at GrantRegister to see if this grant matches your organization.
Match my organization →View application on Grants.gov →·Source: Grants.gov·Last seen Apr 28, 2026